Savaria Corporation's stock is gaining traction on the TSX, reflecting positive investor sentiment.
Savaria Corporation (SIS.TO) is seeing a notable rise in its stock price today, up by 2.89% to CA$30.98. This increase comes as investors respond favorably to the company's recent financial performance and dividend announcements.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Savaria Corporation
SIS.TO
SIS.TO
Savaria Corporation
WealthAwesomeMarket cap
$2.22B
P/E
27.9x
Div. yield
1.79%
Div. / share
$0.55
52W high
$31.95
52W low
$19.08
1W change
-4.62%
Beta
0.98
Analyst Price Targets
Based on analyst covering SIS
Wall Street analysts forecast SIS stock price to rise 16.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$35.00
+16.2% Upside
Current Price
C$30.11
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SIS's historical volatility
30-Day Vol
24.5%
Annualized
90-Day Vol
25.7%
Annualized
Trend (90d)
+0.1%
Annualized drift
90d Mean
C$30.13
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$30.12 | C$27.67 โ C$32.77 |
| 60 trading days | C$30.12 | C$26.72 โ C$33.95 |
| 90 trading days | C$30.13 | C$26.02 โ C$34.88 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: With a market cap of approximately CA$2.22 billion and a steady dividend yield, Savaria Corporation continues to attract attention from investors looking for growth opportunities in the healthcare sector.
Savaria's stock price rises to CA$30.98
The stock's increase of 2.89% reflects positive market sentiment and investor confidence in Savaria's growth trajectory.
Bull case
Savaria's latest financial results show a solid revenue increase and a commitment to shareholder returns through regular dividends. This suggests strong operational performance and a positive outlook for the company.
Bear case
Despite today's gains, potential investors should be cautious about market volatility and the company's P/E ratio of 27.37, which might indicate overvaluation compared to industry peers.
Savaria's Financial Performance
Savaria Corporation recently reported revenue of CA$235.5 million for Q1 2026, marking a 7% increase from the previous year. The net earnings stood at CA$22.7 million, or CA$0.31 per share, showcasing the company's ability to grow even in a competitive market. This positive financial outlook is likely contributing to the stock's rise today.
Dividend Announcements
The company has declared a monthly dividend of CA$0.0467 per common share, payable on July 10, 2026. Such announcements often boost investor confidence, as they indicate a commitment to returning value to shareholders. Savaria's consistent dividend payments may be a key factor in attracting long-term investors.
Market Sentiment and Future Outlook
The current rise in Savaria's stock reflects a broader positive sentiment in the market towards healthcare companies. Investors are increasingly looking for stable growth opportunities, and Savaria's performance metrics suggest it could be a strong candidate for those seeking to invest in the sector. However, potential investors should remain vigilant about market conditions and company valuations.
Advertisement
